150 related articles for article (PubMed ID: 38741216)
21. Cardiotoxicity in autologous haematopoietic stem cell transplantation for systemic sclerosis.
Penglase R; Girgis L; Englert H; Brennan X; Jabbour A; Kotlyar E; Ma D; Moore J
J Scleroderma Relat Disord; 2023 Jun; 8(2):87-100. PubMed ID: 37287946
[TBL] [Abstract][Full Text] [Related]
22. Autologous Hematopoietic Stem Cell Transplantation for Systemic Sclerosis: A Systematic Review and Meta-Analysis.
Shouval R; Furie N; Raanani P; Nagler A; Gafter-Gvili A
Biol Blood Marrow Transplant; 2018 May; 24(5):937-944. PubMed ID: 29374527
[TBL] [Abstract][Full Text] [Related]
23. Autologous hematopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: comparison with secondary progressive multiple sclerosis.
Casanova B; Jarque I; Gascón F; Hernández-Boluda JC; Pérez-Miralles F; de la Rubia J; Alcalá C; Sanz J; Mallada J; Cervelló A; Navarré A; Carcelén-Gadea M; Boscá I; Gil-Perotin S; Solano C; Sanz MA; Coret F
Neurol Sci; 2017 Jul; 38(7):1213-1221. PubMed ID: 28396953
[TBL] [Abstract][Full Text] [Related]
24. Autologous Hematopoietic Stem Cell Therapy of the Subjects with Systemic Sclerosis: Electromyographic Results of the Masticatory Muscles.
Branco T; Oliveira LF; Palinkas M; de Vasconcelos PB; Oliveira MC; Simões BP; Regalo IH; Siéssere S; Regalo SCH
Prague Med Rep; 2020; 121(3):163-171. PubMed ID: 33030145
[TBL] [Abstract][Full Text] [Related]
25. Extracorporeal membrane oxygenation (ECMO) during aplasia: A bridge towards myopericarditis recovery after autologous hematopoietic stem cell transplant for systemic sclerosis and recent Coronarovirus disease (COVID-19) vaccination.
Cacciatore C; Baudet M; Jean E; Presente S; Para M; Sonneville R; Arangalage D; Ait Abdallah N; Sicre de Fontbrune F; Prata PH; Crichi B; Hervier B; Parquet N; Soulat G; Mousseaux E; Burt RK; Farge D
Curr Res Transl Med; 2024 Apr; 72(3):103449. PubMed ID: 38636307
[TBL] [Abstract][Full Text] [Related]
26. [Autologous peripheral stem cell transplantation in systemic sclerosis: An important step forward, but we must temper our enthusiasm!].
Mouthon L
Rev Med Interne; 2023 Dec; ():. PubMed ID: 38057166
[TBL] [Abstract][Full Text] [Related]
27. Systemic Sclerosis as an Indication for Autologous Hematopoietic Cell Transplantation: Position Statement from the American Society for Blood and Marrow Transplantation.
Sullivan KM; Majhail NS; Bredeson C; Carpenter PA; Chatterjee S; Crofford LJ; Georges GE; Nash RA; Pasquini MC; Sarantopoulos S; Storek J; Savani B; St Clair EW
Biol Blood Marrow Transplant; 2018 Oct; 24(10):1961-1964. PubMed ID: 29953945
[TBL] [Abstract][Full Text] [Related]
28. Idiopathic giant cell myocarditis after autologous hematopoietic stem cell transplantation and interleukin-2 immunotherapy: a case report.
Truica CI; Hansen CH; Garvin DF; Meehan KR
Cancer; 1998 Sep; 83(6):1231-6. PubMed ID: 9740090
[TBL] [Abstract][Full Text] [Related]
29. Autologous hematopoietic stem cell transplantation in progressive severe multiple sclerosis.
Pandit AK; Prasad K; Seth T
Ann Indian Acad Neurol; 2015; 18(4):459-63. PubMed ID: 26713025
[TBL] [Abstract][Full Text] [Related]
30. From "being at war" to "getting back on your feet": A qualitative study on experiences of patients with systemic sclerosis treated with hematopoietic stem cell transplantation.
Spierings J; de Bresser CJ; van Rhijn-Brouwer FC; Pieterse A; Vonk MC; Voskuyl AE; de Vries-Bouwstra JK; van Laar JM; Kars MC
J Scleroderma Relat Disord; 2020 Oct; 5(3):202-209. PubMed ID: 35382525
[TBL] [Abstract][Full Text] [Related]
31. Marked and sustained improvement two years after autologous stem cell transplantation in a girl with systemic sclerosis.
Martini A; Maccario R; Ravelli A; Montagna D; De Benedetti F; Bonetti F; Viola S; Zecca M; Perotti C; Locatelli F
Arthritis Rheum; 1999 Apr; 42(4):807-11. PubMed ID: 10211898
[TBL] [Abstract][Full Text] [Related]
32. Esophageal motility in systemic sclerosis before and after autologous hematopoietic cell transplantation.
Woo MMK; Levin D; Li DY; David J; Buresi M; Gupta M; Nasser Y; Andrews CN; Durand C; Osman MS; Jamani K; Weatherald J; Johannson KA; Howlett JG; Hemmati I; Kim H; Curley M; Storek J
Clin Rheumatol; 2023 Dec; 42(12):3267-3274. PubMed ID: 37702810
[TBL] [Abstract][Full Text] [Related]
33. CD34-selected versus unmanipulated autologous haematopoietic stem cell transplantation in the treatment of severe systemic sclerosis: a post hoc analysis of a phase I/II clinical trial conducted in Japan.
Ayano M; Tsukamoto H; Mitoma H; Kimoto Y; Akahoshi M; Arinobu Y; Miyamoto T; Horiuchi T; Niiro H; Nagafuji K; Harada M; Akashi K
Arthritis Res Ther; 2019 Jan; 21(1):30. PubMed ID: 30670057
[TBL] [Abstract][Full Text] [Related]
34. Hematopoietic stem cell transplantation for systemic sclerosis: history and current status.
Burt RK; Milanetti F
Curr Opin Rheumatol; 2011 Nov; 23(6):519-29. PubMed ID: 21857226
[TBL] [Abstract][Full Text] [Related]
35. Pilot trial of intravenous autologous culture-expanded mesenchymal stem cell transplantation in multiple sclerosis.
Cohen JA; Imrey PB; Planchon SM; Bermel RA; Fisher E; Fox RJ; Bar-Or A; Sharp SL; Skaramagas TT; Jagodnik P; Karafa M; Morrison S; Reese Koc J; Gerson SL; Lazarus HM
Mult Scler; 2018 Apr; 24(4):501-511. PubMed ID: 28381130
[TBL] [Abstract][Full Text] [Related]
36. Autologous hematopoietic stem cell transplantation of patients with aggressive relapsing-remitting multiple sclerosis: Danish nation-wide experience.
Jespersen F; Petersen SL; Andersen P; Sellebjerg F; Magyari M; Sørensen PS; Blinkenberg M
Mult Scler Relat Disord; 2023 Aug; 76():104829. PubMed ID: 37364374
[TBL] [Abstract][Full Text] [Related]
37. Low B cell counts as risk factor for infectious complications in systemic sclerosis after autologous hematopoietic stem cell transplantation.
Gernert M; Tony HP; Schwaneck EC; Fröhlich M; Schmalzing M
Arthritis Res Ther; 2020 Aug; 22(1):183. PubMed ID: 32771029
[TBL] [Abstract][Full Text] [Related]
38. Treatment of autoimmune disease by intense immunosuppressive conditioning and autologous hematopoietic stem cell transplantation.
Burt RK; Traynor AE; Pope R; Schroeder J; Cohen B; Karlin KH; Lobeck L; Goolsby C; Rowlings P; Davis FA; Stefoski D; Terry C; Keever-Taylor C; Rosen S; Vesole D; Fishman M; Brush M; Mujias S; Villa M; Burns WH
Blood; 1998 Nov; 92(10):3505-14. PubMed ID: 9808541
[TBL] [Abstract][Full Text] [Related]
39. Consensus statement concerning cardiotoxicity occurring during haematopoietic stem cell transplantation in the treatment of autoimmune diseases, with special reference to systemic sclerosis and multiple sclerosis.
Saccardi R; Tyndall A; Coghlan G; Denton C; Edan G; Emdin M; Farge D; Fassas A; Finke J; Furst D; Lassus M; Mancardi G; Miniati I; Mini E; Pagliai F; Passweg J; Pignone A; van Laar JM; Bocelli-Tyndall C; Matucci-Cerinic M
Bone Marrow Transplant; 2004 Nov; 34(10):877-81. PubMed ID: 15517007
[TBL] [Abstract][Full Text] [Related]
40. Optimization of autologous stem cell transplantation for systemic sclerosis -- a single-center longterm experience in 26 patients with severe organ manifestations.
Henes JC; Schmalzing M; Vogel W; Riemekasten G; Fend F; Kanz L; Koetter I
J Rheumatol; 2012 Feb; 39(2):269-75. PubMed ID: 22247352
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
